StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.77+0.03 (+1.09%)

Close on Nov 16, 2026Market cap $23.10MP/E –Yield –

Evaxion A/S EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2023 it was -$0.81. The highest annual figure on record is -$0.43 in fiscal 2018.

Annual eps

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$0.81–
FY2022Dec 31, 2022-$0.98–
FY2021Dec 31, 2021-$1.26–
FY2020Dec 31, 2020-$0.97–
FY2019Dec 31, 2019-$0.81–
FY2018Dec 31, 2018-$0.43–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2023Jun 30, 2023-$0.21–
Q2 FY2022Jun 30, 2022-$0.20–
Q1 FY2022Mar 31, 2022-$0.25–
Q3 FY2021Sep 30, 2021-$0.27–
Q2 FY2021Jun 30, 2021-$0.36–
Q1 FY2021Mar 31, 2021-$0.23–
Q3 FY2020Sep 30, 2020-$0.26–
Q2 FY2020Jun 30, 2020-$0.24–
Q1 FY2020Mar 31, 2020-$0.20–

More Evaxion A/S figures

See a number that looks wrong?